John Shannon

John Shannon

Directeur Général chez XERIS BIOPHARMA HOLDINGS, INC.

Fortune : 12 M $ au 31/07/2026

64 ans
Health Technology
Commercial Services
Consumer Services

Profil

John Patrick Shannon is currently Chairman & Chief Executive Officer at Xeris Biopharma Holdings, Inc. since 2026.
Former positions include Chief Executive Officer & Director at Catheter Connections, Inc. from 2015 to 2016; Executive Director-Cardiovascular Global at Viatris Holdings LLC from 1991 to 2001; GM-Global Hemophilia & Commercial Excellence at Baxter Healthcare Corp.
from 2001 to 2011; President & Chief Operating Officer at Xeris Pharmaceuticals, Inc. from 2020 to 2021; Head-Sales Operations, Marketing & Strategic at Bock Pharmacal Co.; Vice President & General Manager at Baxter BioScience Corp.
from 2002 to 2012; Vice President-Marketing at Caremark LLC; and Chief Commercial Officer at Durata Therapeutics, Inc. from 2012 to 2014.
Education includes undergraduate studies at Western Illinois University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/04/2026 1 507 143 ( 0,87 % ) 12 M $ 31/07/2026

Postes actifs de John Shannon

SociétésPosteDébut
XERIS BIOPHARMA HOLDINGS, INC. Directeur Général 01/08/2024

Anciens postes connus de John Shannon

SociétésPosteFin
Directeur Général 01/01/2016
DURATA THERAPEUTICS INC Corporate Officer/Principal 01/11/2014
Corporate Officer/Principal 01/01/2012
Corporate Officer/Principal 01/01/2011
Corporate Officer/Principal 01/01/2001
Voir l'expérience en détail de John Shannon

Formation de John Shannon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Caremark LLC

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. John Shannon
🔇